Frank Kirchhoff

25.6k total citations · 5 hit papers
296 papers, 14.0k citations indexed

About

Frank Kirchhoff is a scholar working on Virology, Immunology and Infectious Diseases. According to data from OpenAlex, Frank Kirchhoff has authored 296 papers receiving a total of 14.0k indexed citations (citations by other indexed papers that have themselves been cited), including 215 papers in Virology, 138 papers in Immunology and 114 papers in Infectious Diseases. Recurrent topics in Frank Kirchhoff's work include HIV Research and Treatment (214 papers), Immune Cell Function and Interaction (87 papers) and HIV/AIDS drug development and treatment (64 papers). Frank Kirchhoff is often cited by papers focused on HIV Research and Treatment (214 papers), Immune Cell Function and Interaction (87 papers) and HIV/AIDS drug development and treatment (64 papers). Frank Kirchhoff collaborates with scholars based in Germany, United States and France. Frank Kirchhoff's co-authors include Jan Münch, Ronald C. Desrosiers, Daniel Sauter, Thomas C. Greenough, Michael Schindler, John L. Sullivan, Doreen B. Brettler, Susan Czajak, Prabhat K. Sehgal and M. D. Daniel and has published in prestigious journals such as Science, New England Journal of Medicine and Cell.

In The Last Decade

Frank Kirchhoff

292 papers receiving 13.9k citations

Hit Papers

Absence of Intact nef Sequences in a Long-Term Survivor w... 1992 2026 2003 2014 1995 1992 2020 2022 2022 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Absence of Intact nef Sequences in a Long-Term Survivor with Nonprogressive HIV-1 Infection
    1995 852 citations Frank Kirchhoff et al. profile →
  2. Protective Effects of a Live Attenuated SIV Vaccine with a Deletion in the nef Gene
    1992 842 citations Frank Kirchhoff et al. Science profile →
  3. Structural basis for translational shutdown and immune evasion by the Nsp1 protein of SARS-CoV-2
    2020 549 citations Matthias Thoms, Robert Buschauer et al. Science profile →
  4. Omicron: What Makes the Latest SARS-CoV-2 Variant of Concern So Concerning?
    2022 143 citations Christoph Jung, Dorota Kmieć et al. Journal of Virology profile →
  5. Monkeypox: A New Threat?
    2022 138 citations Dorota Kmieć, Frank Kirchhoff profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Frank Kirchhoff Germany 63 8.8k 5.8k 5.1k 3.6k 3.4k 296 14.0k
M. Juliana McElrath United States 63 8.2k 0.9× 7.5k 1.3× 4.4k 0.9× 3.4k 0.9× 4.4k 1.3× 261 15.1k
Françoise Barré‐Sinoussi France 63 11.9k 1.4× 7.5k 1.3× 7.0k 1.4× 4.5k 1.2× 2.4k 0.7× 216 17.5k
Guido Silvestri United States 57 9.6k 1.1× 7.7k 1.3× 4.4k 0.9× 3.8k 1.1× 1.9k 0.5× 219 14.1k
John C. Kappes United States 54 8.8k 1.0× 4.7k 0.8× 4.9k 1.0× 2.7k 0.7× 4.0k 1.2× 163 13.8k
Yoshio Koyanagi Japan 55 6.4k 0.7× 6.0k 1.0× 3.7k 0.7× 2.1k 0.6× 3.1k 0.9× 222 12.8k
Benhur Lee United States 63 4.3k 0.5× 5.3k 0.9× 4.1k 0.8× 4.4k 1.2× 3.3k 1.0× 202 13.1k
Hanneke Schuitemaker Netherlands 63 10.6k 1.2× 5.8k 1.0× 6.9k 1.3× 2.8k 0.8× 1.9k 0.6× 273 13.4k
Roger J. Pomerantz United States 55 7.2k 0.8× 2.8k 0.5× 4.7k 0.9× 2.8k 0.8× 3.2k 0.9× 207 11.5k
David M. Margolis United States 67 10.4k 1.2× 4.2k 0.7× 8.1k 1.6× 2.8k 0.8× 3.8k 1.1× 304 16.0k
Persephone Borrow United Kingdom 58 5.8k 0.7× 9.7k 1.7× 4.0k 0.8× 3.6k 1.0× 2.4k 0.7× 159 15.3k

Countries citing papers authored by Frank Kirchhoff

Since Specialization
Citations

This map shows the geographic impact of Frank Kirchhoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank Kirchhoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank Kirchhoff more than expected).

Fields of papers citing papers by Frank Kirchhoff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank Kirchhoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank Kirchhoff. The network helps show where Frank Kirchhoff may publish in the future.

Co-authorship network of co-authors of Frank Kirchhoff

This figure shows the co-authorship network connecting the top 25 collaborators of Frank Kirchhoff. A scholar is included among the top collaborators of Frank Kirchhoff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank Kirchhoff. Frank Kirchhoff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zech, Fabian, Christoph Jung, Armando Rodríguez, et al.. (2025). ReaxFF-Guided Optimization of VIRIP-Based HIV-1 Entry Inhibitors. The Journal of Physical Chemistry B. 129(15). 3788–3795. 1 indexed citations
2.
Kmieć, Dorota & Frank Kirchhoff. (2024). Antiviral factors and their counteraction by HIV-1: many uncovered and more to be discovered. Journal of Molecular Cell Biology. 16(2). 6 indexed citations
3.
Volčič, Meta, Rayhane Nchioua, Fabian Zech, et al.. (2024). Attenuated replication and damaging effects of SARS‐CoV‐2 Omicron variants in an intestinal epithelial barrier model. Journal of Medical Virology. 96(7). e29783–e29783. 4 indexed citations
4.
Richard, Jonathan, Gérémy Sannier, Jérémie Prévost, et al.. (2024). CD4 downregulation precedes Env expression and protects HIV-1-infected cells from ADCC mediated by non-neutralizing antibodies. mBio. 15(11). e0182724–e0182724. 2 indexed citations
5.
Bozzo, Caterina Prelli, Stefan Krebs, Alexander Graf, et al.. (2024). Replication competent HIV-guided CRISPR screen identifies antiviral factors including targets of the accessory protein Nef. Nature Communications. 15(1). 3813–3813. 7 indexed citations
6.
Yang, Weijing, et al.. (2024). RPLP1 restricts HIV-1 transcription by disrupting C/EBPβ binding to the LTR. Nature Communications. 15(1). 5290–5290. 3 indexed citations
7.
Bozzo, Caterina Prelli, Dorota Kmieć, Rayhane Nchioua, et al.. (2023). Endogenous IFITMs boost SARS-coronavirus 1 and 2 replication whereas overexpression inhibits infection by relocalizing ACE2. iScience. 26(4). 106395–106395. 9 indexed citations
8.
Wang, Qingxing, Alina Seidel, Janis A. Müller, et al.. (2023). Determinants of species-specific utilization of ACE2 by human and animal coronaviruses. Communications Biology. 6(1). 1051–1051. 8 indexed citations
9.
Prévost, Jérémie, Jonathan Richard, Romain Gasser, et al.. (2022). Detection of the HIV-1 Accessory Proteins Nef and Vpu by Flow Cytometry Represents a New Tool to Study Their Functional Interplay within a Single Infected CD4 + T Cell. Journal of Virology. 96(6). e0192921–e0192921. 8 indexed citations
10.
Schmidt, Hanna, Alexander Sauter, Fabian Zech, et al.. (2022). Serially passaged, conditionally reprogrammed nasal epithelial cells as a model to study epithelial functions and SARS-CoV-2 infection. American Journal of Physiology-Cell Physiology. 322(4). C591–C604. 3 indexed citations
11.
Zech, Fabian, Tatjana Weil, Alina Seidel, et al.. (2022). Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination Boosts Neutralizing Activity Against Seasonal Human Coronaviruses. Clinical Infectious Diseases. 75(1). e653–e661. 14 indexed citations
12.
Hayn, Manuel, Armando Rodríguez, Solange Vidal, et al.. (2021). Natural cystatin C fragments inhibit GPR15-mediated HIV and SIV infection without interfering with GPR15L signaling. Proceedings of the National Academy of Sciences. 118(3). 12 indexed citations
13.
Zhao, Zhe, Riku Fagerlund, Helena Tossavainen, et al.. (2021). Evolutionary plasticity of SH3 domain binding by Nef proteins of the HIV-1/SIVcpz lentiviral lineage. PLoS Pathogens. 17(11). e1009728–e1009728. 5 indexed citations
14.
Bosso, Matteo, Caterina Prelli Bozzo, Dominik Hotter, et al.. (2020). Nuclear PYHIN proteins target the host transcription factor Sp1 thereby restricting HIV-1 in human macrophages and CD4+ T cells. PLoS Pathogens. 16(8). e1008752–e1008752. 30 indexed citations
15.
Thoms, Matthias, Robert Buschauer, Michael Ameismeier, et al.. (2020). Structural basis for translational shutdown and immune evasion by the Nsp1 protein of SARS-CoV-2. Science. 369(6508). 1249–1255. 549 indexed citations breakdown →
16.
Langer, Simon, Christian Hammer, Lukas Klein, et al.. (2019). HIV-1 Vpu is a potent transcriptional suppressor of NF-κB-elicited antiviral immune responses. eLife. 8. 53 indexed citations
17.
Guidi, Novella, Mehmet Saçma, Ludger Ständker, et al.. (2017). Osteopontin attenuates aging‐associated phenotypes of hematopoietic stem cells. The EMBO Journal. 36(7). 840–853. 117 indexed citations
18.
Bächle, Susanna M., et al.. (2015). Involvement of a C-terminal motif in the interference of primate lentiviral Vpu proteins with CD1d-mediated antigen presentation. Scientific Reports. 5(1). 9675–9675. 13 indexed citations
19.
Sauter, Daniel, Shariq M. Usmani, Joëlle V. Fritz, et al.. (2012). Reacquisition of Nef-Mediated Tetherin Antagonism in a Single In Vivo Passage of HIV-1 through Its Original Chimpanzee Host. Cell Host & Microbe. 12(3). 373–380. 29 indexed citations
20.
Strauß, Gudrun, Jonathan A. Lindquist, Nathalie J. Arhel, et al.. (2009). CD95 co-stimulation blocks activation of naive T cells by inhibiting T cell receptor signaling. The Journal of Experimental Medicine. 206(6). 1379–1393. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Juliana McElrath Breakdown of academic impact, for papers by Françoise Barré‐Sinoussi Breakdown of academic impact, for papers by Guido Silvestri Breakdown of academic impact, for papers by John C. Kappes Breakdown of academic impact, for papers by Yoshio Koyanagi Breakdown of academic impact, for papers by Benhur Lee Breakdown of academic impact, for papers by Hanneke Schuitemaker Breakdown of academic impact, for papers by Roger J. Pomerantz Breakdown of academic impact, for papers by David M. Margolis Breakdown of academic impact, for papers by Persephone Borrow
Rankless by CCL
2026